ESPR earnings: a positive outcome, +10.3%

On February 27, 2024, Esperion Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.3% in the window around the event. It had already run +22.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.